ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP04

Reclaiming Medical Autonomy Through Healthcare Advocacy

Christele Felix1, 1LADA, Rosedale, New York

Meeting: 2019 ACR/ARP Annual Meeting

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Patient Perspectives Poster Session

Session Type: Poster Session (Sunday)

Session Time: 11:30AM-1:30PM

Background/Purpose: When I received my diagnosis in 2007, I had never heard the word Lupus before and had no idea what it meant. I don’t remember having any reaction to the news, because I did not know to be alarmed by the gravity of the situation. Newly diagnosed patients often cannot imagine the extent to which this health issue will take over their lives. I was diagnosed at 18 years old, while trying to juggle with young adulthood and an ambitious college career. I would soon discover that there was a lot to learn in managing a complex and long term condition like Lupus. In doing so I’d learn to raise my voice and help others raise theirs.

Treatment: Evolving as a chronic patient takes a lot of reevaluation on patients’ part of what their priorities are. It takes some time, and is an ongoing experience, to learn how to appropriately manage stress and energy levels, in addition of staying on top of a complex treatment regiment and coordinating with a health team of multiple specialists. Very often, patients also learn a lot about patients’ rights issues. I got involved in a support group as a quiet participant, observing and learning until I found my own voice. Pretty soon, and bolstered by the positive doctor-patient interactions with my rheumatologist and gastroenterologist, I became very vocal about patient-centered care and patient-centered research. My goals as I navigated this new life with chronic illness were to improve quality of life and make a better future for myself and for people living with similar conditions.

Maintenance: My background in research and education made it easier to piece together the medical jargon related to Lupus in medicine and research, and I have enjoyed educating myself so that I can educate others as well. As a result of this, I took a more active role in my care; my health and my quality of life have improved dramatically. My new-found drive to advocate on behalf of myself and others has influenced my personal health in a great way. Patients’ motivation can falter in the face of such a long term condition, and it often takes years to figure out the right approach that works for each person. As patients find their voices and stand up for their rights and the rights of patients like them, they may discover that their personal health also improves for the better.

Quality of Life: My advocacy sustains me, both as an individual and as a patient. I believe that it is very important to let patients know that they have a voice that they can use if they so wish. Patient education starts with the patient itself, then gradually evolves to benefit others. As part of a community of patients and patient advocates, we give each other support and encouragement, as well as medicine reminders and helpful tips for people living with Lupus. Additionally, I constantly seek to have conversations with doctors and health professionals on ways to engage patients and improve their quality of life.


Disclosure: C. Felix, Aurinia Pharmaceuticals Inc, 5.

To cite this abstract in AMA style:

Felix C. Reclaiming Medical Autonomy Through Healthcare Advocacy [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/reclaiming-medical-autonomy-through-healthcare-advocacy/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reclaiming-medical-autonomy-through-healthcare-advocacy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology